Introduction

AuthorEuropean Monitoring Centre for Drugs and Drug Addiction (EU body or agency), Europol (EU body or agency)
Pages7-8
7
Introduction
It is with great pleasure that we present this new joint report by the European Monitoring
Centre for Drugs and Drug Addiction (EMCDDA) and the European Union Agency for
Law Enforcement Cooperation (Europol). e report focuses on the drug supply chain,
the associated criminal activities and actors, and the policy, strategic and operational
responses to these. It highlights the importance of the drug market as a key source of
revenue for organised crime, its links to terrorism and wider criminal activity, and the
negative impact it has on the legal economy and society more generally, demonstrating how
the drug trade and its wider ramications aect all aspects of the European security agenda
and why tackling them is essential to the European Union’s ght against serious and
organised crime. It describes, for example, the links between drugs and tracking in human
beings, the increasing levels of violence and corruption associated with the drug trade, and
the environmental harms from drug production — all of which are now increasingly visible
within Europe.
e analysis underpinning this report is strengthened by the complementary perspectives
our two organisations bring to this topic. e synthesis of the operational intelligence
provided by Europol, with research data and the information available from the ongoing
monitoring undertaken by EMCDDA has produced a report and accompanying online
materials that provide a contemporary strategic and action-oriented analysis of Europe’s
drug markets. is will be a valuable source of evidence to inform policies and actions and
a strategic understanding of how criminal enterprises operate to assist the targeting of
operational activities.
is is the third EU Drug Markets Report – it builds upon the analysis provided in the 2013
and 2016 editions and many of the conclusions and recommendations of the previous
reports remain relevant today. However, this new report is able to paint a richer picture
and provides additional insights. For example, it highlights the way in which many of the
harms more traditionally associated with drug production and tracking outside Europe
are becoming a growing threat within the EU. It also shows how the EU is increasingly
important as both a drug producing and transit region, while EU-based organised crime
groups are adapting their modi operandi and extending their reach, resulting in both
increased harms and new challenges for enforcement.
e increasingly globalised and digitally-enabled nature of drug markets illustrated in
the report means that the law enforcement activities countering these are becoming
more complex and resource intensive. is underlines the need to ensure the adequate
resourcing and prioritisation of supply reduction activities, including not only law
enforcement interventions and investigations, but also importantly activities to enhance
international cooperation, at both the national and EU level. e continued development of
joint programmes, networks, partnerships and capacity building in relation to drug supply
reduction among key regional partners, such as the Western Balkan and other neighbouring
countries as well as those in the drug producing regions of Latin America and Central Asia,
therefore needs to remain a high priority.
is report also illustrates the importance of continued investment in research, monitoring
and analysis, which is necessary to underpin the exible and dynamic responses that
Europe requires to tackle the problems generated by drug markets. Having a reliable and
comprehensive picture of the drug market and its wider impacts available is essential for
decision-makers at both the national and EU Level as well as to law enforcement authorities
in planning resource allocation and deciding on investigative focus areas. e EU Drug
Markets Report helps to address these needs by providing an indispensable reference point

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT